| Identification | Back Directory | [Name]
3'-O-Acetyl-2'-deoxy-N2-isobutyrylguanosine | [CAS]
74925-81-8 | [Synonyms]
3-O-ACETYL-N2-ISOBUTYRYL-2-DG
3'-O-Acetyl-2'-deoxy-N2-isobutyrylguanosine
3’-O-Acetyl-N2-iso-Butyroyl-2’-deoxy-guanosine
Guanosine, 2'-deoxy-N-(2-methyl-1-oxopropyl)-, 3'-acetate | [Molecular Formula]
C16H21N5O6 | [MDL Number]
MFCD00057881 | [MOL File]
74925-81-8.mol | [Molecular Weight]
379.37 |
| Hazard Information | Back Directory | [Uses]
3’-O-Acetyl-N2-iso-Butyroyl-2’-deoxy-guanosine is a purine nucleoside analog. Purine nucleoside analogs have broad antitumor activity targeting indolent lymphoid malignancies. Anticancer mechanisms in this process rely on inhibition of DNA synthesis, induction of apoptosis, etc[1]. | [References]
[1] Robak T, Robak P. Purine nucleoside analogs in the treatment of rarer chronic lymphoid leukemias. Curr Pharm Des. 2012;18(23):3373-88. DOI:10.2174/138161212801227005 |
|
| Company Name: |
NewCan Biotech Limited
|
| Telephone: |
+86-571-86912261 19975279805 |
| Website: |
https://www.newcanbio.com/ |
|